GB0817585D0 - Novel compositions and methods - Google Patents
Novel compositions and methodsInfo
- Publication number
- GB0817585D0 GB0817585D0 GB0817585A GB0817585A GB0817585D0 GB 0817585 D0 GB0817585 D0 GB 0817585D0 GB 0817585 A GB0817585 A GB 0817585A GB 0817585 A GB0817585 A GB 0817585A GB 0817585 D0 GB0817585 D0 GB 0817585D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- methods
- novel compositions
- compositions
- novel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/18—[b, e]-condensed with two six-membered rings
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0817585A GB2463883A (en) | 2008-09-25 | 2008-09-25 | A pharmaceutical composition comprising an A-SMase inhibitor and an NO-donor |
PCT/GB2009/051262 WO2010035047A1 (en) | 2008-09-25 | 2009-09-25 | Binary compositions comprising an no-donor and an a-smase inhibitor for the treatment of respiratory diseases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0817585A GB2463883A (en) | 2008-09-25 | 2008-09-25 | A pharmaceutical composition comprising an A-SMase inhibitor and an NO-donor |
Publications (2)
Publication Number | Publication Date |
---|---|
GB0817585D0 true GB0817585D0 (en) | 2008-11-05 |
GB2463883A GB2463883A (en) | 2010-03-31 |
Family
ID=40019565
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0817585A Withdrawn GB2463883A (en) | 2008-09-25 | 2008-09-25 | A pharmaceutical composition comprising an A-SMase inhibitor and an NO-donor |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB2463883A (en) |
WO (1) | WO2010035047A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112724103A (en) * | 2020-12-16 | 2021-04-30 | 广安凯特制药有限公司 | Isopromazine specific impurity and analysis method and removal method thereof |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104610130A (en) * | 2015-01-22 | 2015-05-13 | 华东理工常熟研究院有限公司 | Amlodipine-palmic acid ionic liquid as well as preparation method and application thereof |
US11517557B2 (en) | 2017-07-13 | 2022-12-06 | Tonix Pharmaceuticals Holding Corp. | Analogs of cyclobenzaprine and amitriptyline |
WO2020163966A1 (en) * | 2019-02-14 | 2020-08-20 | Algernon Pharmaceuticals Inc. | Compositions and methods for treating idiopathic pulmonary fibrosis |
KR102422449B1 (en) * | 2019-10-18 | 2022-07-20 | 연세대학교 산학협력단 | A composition for preventing, alleviating or treating tuberculosis and infected disease by nontuberculous mycobacteria |
CN111008486B (en) * | 2019-12-27 | 2022-11-01 | 中国矿业大学 | Method for cutting coal wall and counting lump coal rate by 2D simulation fully-mechanized face roller |
CN112457358B (en) * | 2020-12-11 | 2022-05-31 | 上海交通大学 | Compound, nitric oxide donor prodrug compound, preparation method and application thereof |
CN113730409B (en) * | 2021-11-01 | 2022-06-14 | 济南市中心医院 | Application of quinacrine in preparation of medicine for treating pulmonary fibrosis |
CN116675620A (en) * | 2022-02-22 | 2023-09-01 | 东南大学 | NO donor compound, preparation method, pharmaceutical composition and application thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69133584T4 (en) * | 1990-12-05 | 2009-11-19 | The General Hospital Corp., Boston | Apparatus for treating a pulmonary constriction and asthma |
DE19519056A1 (en) * | 1995-05-24 | 1997-01-16 | Klinge Co Chem Pharm Fab | Use of antidepressants for the treatment of asthma and / or respiratory diseases by inhalation |
US7279176B1 (en) * | 1999-09-02 | 2007-10-09 | Rice University | Nitric oxide-producing hydrogel materials |
AU2002310511B2 (en) * | 2001-07-09 | 2007-12-06 | Combinatorx, Incorporated | Combinations for the treatment of inflammatory disorders |
-
2008
- 2008-09-25 GB GB0817585A patent/GB2463883A/en not_active Withdrawn
-
2009
- 2009-09-25 WO PCT/GB2009/051262 patent/WO2010035047A1/en active Application Filing
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112724103A (en) * | 2020-12-16 | 2021-04-30 | 广安凯特制药有限公司 | Isopromazine specific impurity and analysis method and removal method thereof |
Also Published As
Publication number | Publication date |
---|---|
GB2463883A (en) | 2010-03-31 |
WO2010035047A1 (en) | 2010-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL210153A0 (en) | Nutrigenomics methods and compositions | |
IL212822A0 (en) | Anti-cxcr1 compositions and methods | |
GB0815872D0 (en) | Novel method and compositions | |
ZA201001300B (en) | Antigen-asjuvant compositions and methods | |
PL2137210T3 (en) | Novel method and compositions | |
GB0819530D0 (en) | Methods and compositions | |
FI3812360T3 (en) | Monochlorotrifluoropropene compounds and compositions and methods using same | |
EP2334804A4 (en) | Co-culture compositions and methods | |
IL210559A0 (en) | Novel compositions and methods | |
IL210588A0 (en) | Novel compositions and methods | |
GB0721291D0 (en) | Methods and compositions | |
GB0817585D0 (en) | Novel compositions and methods | |
GB0809912D0 (en) | Novel compositions and uses thereof | |
GB0719526D0 (en) | Compositions and methods | |
GB0901494D0 (en) | Compositions and Methods | |
SI2320888T1 (en) | Laidlomycin compositions and methods | |
GB0811250D0 (en) | Methods and compositions | |
GB0811152D0 (en) | Methods and compositions | |
GB0803464D0 (en) | Methods and compositions | |
GB0818399D0 (en) | Methods and compositions | |
GB0816534D0 (en) | Compositions and methods | |
GB0802079D0 (en) | Method and compositions | |
GB0723775D0 (en) | Methods and compositions | |
GB0724549D0 (en) | Compositions and methods | |
GB0717683D0 (en) | Compositions and methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
COOA | Change in applicant's name or ownership of the application |
Owner name: PHARMAPATENTS GLOBAL LTD Free format text: FORMER OWNER: PHARMA PATENTS LTD |
|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |